March 2025
1. TAKAHASHI EA, Sista AK, Addison D, Bikdeli B, et al
   Disparities in Current Pulmonary Embolism Management and Outcomes: A Scientific Statement From the American Heart Association.
   Circulation. 2025 Mar 20. doi: 10.1161/CIR.0000000000001306.
   

   >> Share

   
   February 2025
2. RAO SV, Gutierrez JAT
   A Win for Clinical Evidence: The First Head-to-Head Trial of Interventional Strategies for the Treatment of Pulmonary Embolism.
   Circulation. 2025;151:274-276.
   

   >> Share

   
   November 2024
3. YAMASHITA Y, Morimoto T, Muraoka N, Shioyama W, et al
   Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).
   Circulation. 2024 Nov 18. doi: 10.1161/CIRCULATIONAHA.124.072758.
   

   >> Share

   
   October 2024
4. JABER WA, Gonsalves CF, Stortecky S, Horr S, et al
   Large-bore Mechanical Thrombectomy Versus Catheter-directed Thrombolysis in the Management of Intermediate-risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial.
   Circulation. 2024 Oct 29. doi: 10.1161/CIRCULATIONAHA.124.072364.
   

   >> Share

   
   
5. DELCROIX M, Pepke-Zaba J, D'Armini AM, Fadel E, et al
   Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy.
   Circulation. 2024;150:1354-1365.
   

   >> Share

   
   September 2024
6. ROSENFIELD K, Bowers TR, Barnett CF, Davis GA, et al
   Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report from the Pulmonary Embolism Research Collaborative.
   Circulation. 2024 Sep 12. doi: 10.1161/CIRCULATIONAHA.124.067482.
   

   >> Share

   
   
7. SINGH S, Kumar P, Padwad YS, Jaffer FA, et al
   Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach.
   Circulation. 2024;150:884-898.
   

   >> Share

   
   June 2024
8. 
   Correction to: Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
   Circulation. 2024;149:e1412.
   

   >> Share

   
   March 2024
9. AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
   Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
   Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
   

   >> Share

   
   December 2023
10. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    

    >> Share

    
    November 2023
11. GOTO S, Goto S
    Clinical Course of Isolated Distal Venous Thromboembolism in Patients With Active Cancer in a Nation With an Overall Low Risk of Thrombosis.
    Circulation. 2023;148:1677-1679.
    

    >> Share

    
    
12. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    

    >> Share

    
    March 2023
13. LASSEN MCH, Modin D, Skaarup KG, Johansen ND, et al
    Risk of Incident Thromboembolic and Ischemic Events After COVID-19 Vaccination Compared With SARS-CoV-2 Infection.
    Circulation. 2023;147:843-845.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share